Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Interferon-γ: an overview of signals, mechanisms and functions

Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811

Effects of chloroquine on viral infections: an old drug against today's diseases

Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268

Tumor necrosis factor: a pleiotropic cytokine and therapuetic target

Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063

Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., & Cunningham, J. M. (2005) · Science · doi:10.1126/science.1110656 · Cited by 826

Neopterin as a Marker for Immune System Activation

Murr, C., Widner, B., Wirleitner, B., & Fuchs, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605082 · Cited by 738

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

Keyaerts, E., Vijgen, L., Maes, P., Neyts, J., & Ranst, M. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 649

The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor

Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599

Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques

Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576

A system for functional analysis of Ebola virus glycoprotein

Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575

New insights into the antiviral effects of chloroquine

Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

Baize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551

Characterization of Reemerging Chikungunya Virus

Sourisseau, M., Schilte, C., Casartelli, N., Trouillet, C., Guivel-Benhassine, F., Rudnicka, D., Sol-Foulon, N., Roux, K. L., Prevost, M.-C., Fsihi, H., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030089 · Cited by 509

Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases

Al-Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 467

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

Nabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413

Human asymptomatic Ebola infection and strong inflammatory response

Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411

Inflammatory responses in Ebola virus-infected patients

BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01800.x · Cited by 370

Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model

Yan, Y., Zou, Z., Sun, Y., Li, X., Xu, K.-F., Wei, Y., Jin, N., & Jiang, C. (2013) · Cell Research · doi:10.1038/cr.2012.165 · Cited by 353

A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults

Tricou, V., Minh, N. N., Van, T. P., Lee, S. J., Farrar, J., Wills, B., Tran, H. T., & Simmons, C. P. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000785 · Cited by 329

Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus Infection

Villinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307

Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry

Daecke, J., Fackler, O., Dittmar, M. T., & Kräusslich, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1581-1594.2005 · Cited by 262

Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins

Yang, Z.-Y., Delgado, R., Xu, L., Todd, R. F., Nabel, E. G., Sanchez, A., & Nabel, G. J. (1998) · Science · doi:10.1126/science.279.5353.1034 · Cited by 261

Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis

Munster, T., Gibbs, J. P., Shen, D., Baethge, B. A., Botstein, G. R., Caldwell, J., Dietz, F., Ettlinger, R., Golden, H. E., Lindsley, H., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10307 · Cited by 249

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

Madrid, P. B., Chopra, S., Manger, I. D., Gilfillan, L., Keepers, T. R., Shurtleff, A. C., Green, C. E., Iyer, L. V., Dilks, H. H., Davey, R. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060579 · Cited by 247

On Chikungunya Acute Infection and Chloroquine Treatment

Lamballerie, X. D., Boisson, V., Reynier, J.-C., Enault, S., Charrel, R. N., Flahault, A., Roques, P., & Grand, R. L. (2008) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2008.0049 · Cited by 245

Chloroquine enhances human CD8 + T cell responses against soluble antigens in vivo

Accapezzato, D., Visco, V., Francavilla, V., Molette, C., Donato, T., Paroli, M., Mondelli, M. U., Doria, M., Torrisi, M. R., & Barnaba, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051106 · Cited by 217

Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial

Paton, N. I., Lee, L., Xu, Y., Ooi, E. E., Cheung, Y. B., Archuleta, S., Wong, G., & Smith, A. W. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70065-2 · Cited by 189

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy–treated immunologic nonresponders

Piconi, S., Parisotto, S., Rizzardini, G., Passerini, S., Terzi, R., Argenteri, B., Meraviglia, P., Capetti, A., Biasin, M., Trabattoni, D., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329060 · Cited by 180

Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy

Paton, N. I., Goodall, R. L., Dunn, D. T., Franzen, S., Collaço‐Moraes, Y., Gazzard, B., Williams, I. G., Fisher, M., Winston, A., Fox, J., et al. (2012) · JAMA · doi:10.1001/jama.2012.6936 · Cited by 163

Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1

Sperber, K. E., Louie, M. J., Kraus, T., Proner, J., Sapira, E., Lin, S., Stecher, V. J., & Mayer, L. (1995) · Clinical Therapeutics · doi:10.1016/0149-2918(95)80039-5 · Cited by 156

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.

Geisbert, T. W., Strong, J. E., & Feldmann, H. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv284 · Cited by 144

Inhibition of Chikungunya Virus Infection in Cultured Human Muscle Cells by Furin Inhibitors

Ozden, S., Lucas‐Hourani, M., Ceccaldi, P., Basak, A., Valentine, M., Benjannet, S., Hamelin, J., Jacob, Y., Mamchaoui, K., Mouly, V., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802444200 · Cited by 143

Ebola virus uses clathrin-mediated endocytosis as an entry pathway

Bhattacharyya, S., Warfield, K. L., Ruthel, G. T., Bavari, S., Aman, M. J., & Hope, T. J. (2010) · Virology · doi:10.1016/j.virol.2010.02.015 · Cited by 142

Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy

Mizui, T., Yamashina, S., Tanida, I., Takei, Y., Ueno, T., Sakamoto, N., Ikejima, K., Kitamura, T., Enomoto, N., Sakai, T., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0132-9 · Cited by 141

In vitro inhibition of human influenza A virus replication by chloroquine.

Ooi, E. E., Chew, J. S. W., Loh, J. P., & Chua, R. (2006) · Virology Journal · doi:10.1186/1743-422x-3-39 · Cited by 140

Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection

Murray, S. M., Down, C. M., Boulware, D. R., Stauffer, W. M., Cavert, W. P., Schacker, T. W., Brenchley, J. M., & Douek, D. C. (2010) · Journal of Virology · doi:10.1128/jvi.01466-10 · Cited by 138

Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model

Dowall, S., Bosworth, A., Watson, R. J., Bewley, K. R., Taylor, I., Rayner, E. L., Hunter, L. E., Pearson, G., Easterbrook, L., Pitman, J. K., et al. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000309 · Cited by 127

Autophagy Benefits the Replication of Newcastle Disease Virus in Chicken Cells and Tissues

Sun, Y., Yu, S., Ding, N., Meng, C., Meng, S., Zhang, S., Zhan, Y., Qiu, X., Tan, L., Chen, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01849-13 · Cited by 123

Anti-HIV Effects of Chloroquine

Savarino, A., Lucia, M. B., Rastrelli, E., Rutella, S., Golotta, C., Morra, E., Tamburrini, E., Perno, C. F., Boelaert, J. R., Sperber, K. E., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200403010-00002 · Cited by 117

Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and Hydroxychloroquine

Laaksonen, A.-L., Koskiahde, V., & Juva, K. (1974) · Scandinavian Journal of Rheumatology · doi:10.3109/03009747409115809 · Cited by 117

Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity

Savarino, A., Gennero, L., Chen, H. C., Serrano, D., Malavasi, F., Boelaert, J. R., & Sperber, K. E. (2001) · AIDS · doi:10.1097/00002030-200111230-00002 · Cited by 115

Long term effectiveness of antimalarial drugs in rheumatic diseases

Aviña-Zubieta, J. A., Galindo-Rodrı́guez, G., Newman, S. C., et al. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.10.582 · Cited by 114

The anti-HIV-1 activity of chloroquine

Savarino, A., Gennero, L., Sperber, K. E., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00139-6 · Cited by 111

Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity

Boonyasuppayakorn, S., Reichert, E. D., Manzano, M., Nagarajan, K., & Padmanabhan, R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.03.014 · Cited by 111

Entry of Feline Calicivirus Is Dependent on Clathrin-Mediated Endocytosis and Acidification in Endosomes

Stuart, A. D., & Brown, T. D. K. (2006) · Journal of Virology · doi:10.1128/jvi.02452-05 · Cited by 108

Chikungunya virus: an update on antiviral development and challenges

Kaur, P., & Chu, J. J. H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.002 · Cited by 107

Mechanism of Borna Disease Virus Entry into Cells

Gonzalez‐Dunia, D., Cubitt, B., & de la Torre, J. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.783-788.1998 · Cited by 106

Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine

Chiang, G. H., Sassaroli, M., Louie, M. J., Chen, H., Stecher, V. J., & Sperber, K. E. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80063-4 · Cited by 103

Potential and Emerging Treatment Options for Ebola Virus Disease

Bishop, B. M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014561227 · Cited by 103

Chloroquine and Hydroxychloroquine as Inhibitors of Human Immunodeficiency Virus (HIV-1) Activity

Romanelli, F., Smith, K. M., & Hoven, A. D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383791 · Cited by 102

Confronting an influenza pandemic with inexpensive generic agents: can it be done?

Fedson, D. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70070-7 · Cited by 99

Chloroquine Modulates HIV-1-Induced Plasmacytoid Dendritic Cell Alpha Interferon: Implication for T-Cell Activation

Martinson, J., Montoya, C. J., Úsuga, X., Ronquillo, R., LANDAY, A. L., & Desai, S. N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01246-09 · Cited by 96

Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis

Augustijns, P., Geusens, P., & Verbeke, N. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280130 · Cited by 94

Vacuolar ATPase in Phagosome-Lysosome Fusion

Kissing, S., Hermsen, C., Repnik, U., Nesset, C. K., von Bargen, K., Griffiths, G., Ichihara, A., Lee, B. S., Schwake, M., Brabander, J. K. D., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628891 · Cited by 93

Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication

Meng, C., Zhou, Z., Jiang, K., Yu, S., Jia, L., Wu, Y., Liu, Y., Meng, S., & Ding, C. (2012) · Archives of Virology · doi:10.1007/s00705-012-1270-6 · Cited by 92

Hydroxychloroquine

Tobin, D. R. (1982) · Archives of Ophthalmology · doi:10.1001/archopht.1982.01030030083006 · Cited by 81

Multiscale perspectives of virus entry via endocytosis

Barrow, E. S., Nicola, A. V., & Liu, J. (2013) · Virology Journal · doi:10.1186/1743-422x-10-177 · Cited by 80

Chloroquine interferes with dengue‐2 virus replication in U937 cells

Farias, K. J. S., Machado, P. R. L., Almeida, R. F., de Aquino, A. A., & da Fonseca, B. A. L. (2014) · Microbiology and Immunology · doi:10.1111/1348-0421.12154 · Cited by 78

Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry

Long, J. S., Wright, E., Molesti, E., Temperton, N. J., & Barclay, W. (2015) · F1000Research · doi:10.12688/f1000research.6085.2 · Cited by 78

Lysosomotropic agents as HCV entry inhibitors

Ashfaq, U. A., Javed, T., Rehman, S., Nawaz, Z., & Riazuddin, S. A. (2011) · Virology Journal · doi:10.1186/1743-422x-8-163 · Cited by 76

Dengue Virus Activates Membrane TRAIL Relocalization and IFN-α Production by Human Plasmacytoid Dendritic Cells In Vitro and In Vivo

Gandini, M., Gras, C., de Azeredo, E. L., Pinto, L. M. D. O., Smith, N., Desprès, P., da Cunha, R. V., de Souza, L. J., Kubelka, C. F., & Herbeuval, J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002257 · Cited by 74

Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses

Trani, L. D., Savarino, A., Campitelli, L., Norelli, S., Puzelli, S., D'Ostilio, D., Vignolo, E., Donatelli, I., & Cassone, A. (2007) · Virology Journal · doi:10.1186/1743-422x-4-39 · Cited by 73

Antimalarial drugs for rheumatoid arthritis

Mackenzie, A. H. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90474-6 · Cited by 73

Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+T-lymphocytes

Naarding, M. A., Baan, E., Pollakis, G., & Paxton, W. A. (2007) · Retrovirology · doi:10.1186/1742-4690-4-6 · Cited by 72

Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?

Borba, E. F., Saad, C. G. S., Pasoto, S. G., et al. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/ker427 · Cited by 71

Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV ‐infected patients receiving antiretroviral therapy

Jp, R., Angel, J. B., Patel, M., Kanagaratham, C., Radzioch, D., Kema, I. P., Gilmore, N. J., Ancuța, P., Singer, J., & Jenabian, M. (2014) · HIV Medicine · doi:10.1111/hiv.12171 · Cited by 70

Cathepsin B & L Are Not Required for Ebola Virus Replication

Marzi, A., Reinheckel, T., & Feldmann, H. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001923 · Cited by 66

Endocytosis-mediated HIV-1 entry and its significance in the elusive behavior of the virus in astrocytes

Chauhan, A., Mehla, R., Vijayakumar, T. S., & Handy, I. (2014) · Virology · doi:10.1016/j.virol.2014.03.002 · Cited by 63

Dengue-3 Virus Entry into Vero Cells: Role of Clathrin-Mediated Endocytosis in the Outcome of Infection

Piccini, L. E., Castilla, V., & Damonte, E. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140824 · Cited by 59

A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus

Ekins, S., Freundlich, J. S., & Coffee, M. P. (2014) · F1000Research · doi:10.12688/f1000research.5741.2 · Cited by 58

Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells

Jiang, K., Li, Y., Zhu, Q., Xu, J., Wang, Y., Deng, W., Liu, Q., Zhang, G., & Meng, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-551 · Cited by 56

Entry of Newcastle Disease Virus into the host cell: Role of acidic pH and endocytosis

Sánchez-Felipe, L., Villar, E., & Muñoz‐Barroso, I. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.08.008 · Cited by 52

Cell Entry of Borna Disease Virus Follows a Clathrin-Mediated Endocytosis Pathway That Requires Rab5 and Microtubules

Clemente, R., & de la Torre, J. C. (2009) · Journal of Virology · doi:10.1128/jvi.00990-09 · Cited by 48

From endocytosis to membrane fusion: emerging roles of dynamin in virus entry

Sun, Y., & Tien, P. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.694412 · Cited by 47

Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents

Uneke, C. J., & Ogbonna, A. (2008) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2008.06.017 · Cited by 43

Endosomal acidification and cathepsin L activity is required for calicivirus replication

Shivanna, V., Kim, Y., & Chang, K. (2014) · Virology · doi:10.1016/j.virol.2014.07.025 · Cited by 38

The enigma of the clandestine association between chloroquine and HIV ‐1 infection

Chauhan, A., & Tikoo, A. (2015) · HIV Medicine · doi:10.1111/hiv.12295 · Cited by 36

The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir

Kraft, T. E., Armstrong, C. M., Heitmeier, M. R., John, A. R. O., & Hruz, P. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00899-15 · Cited by 33

Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis

Wang, H., & Jiang, C. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0061-0 · Cited by 33

RNAi Induces Innate Immunity through Multiple Cellular Signaling Pathways

Meng, Z., Zhang, X., Wu, J., Pei, R., Xu, Y., Yang, D., Roggendorf, M., & Lu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064708 · Cited by 31

Alternative endocytosis pathway for productive entry of hepatitis C virus

Matsuda, M., Suzuki, R., Kataoka, C., Watashi, K., Aizaki, H., Kato, N., Matsuura, Y., Suzuki, T., & Wakita, T. (2014) · Journal of General Virology · doi:10.1099/vir.0.068528-0 · Cited by 24

Characterization of TAP‐Independent and Brefeldin A‐Resistant Presentation of Sendai Virus Antigen to CD8+ Cytotoxic T Lymphocytes

Zhou, X., Liu, T., Franksson, L., Lederer, E., Ljunggren, H., & Jondal, M. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03627.x · Cited by 21

Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection

Brouwers, J., Vermeire, K., Schols, D., & Augustijns, P. (2008) · Virology · doi:10.1016/j.virol.2008.06.005 · Cited by 21

Reconstitution of the receptor-binding motif of the SARS coronavirus

Freund, N. T., Roitburd‐Berman, A., Sui, J., Marasco, W. A., & Gershoni, J. M. (2015) · Protein Engineering Design and Selection · doi:10.1093/protein/gzv052 · Cited by 19

Immunogenicity and Safety of a Booster Dose of an Investigational Adjuvanted Polyprotein HIV-1 Vaccine in Healthy Adults and Effect of Administration of Chloroquine

Leroux-Roels, G. G., Bourguignon, P., Willekens, J., Janssens, M., Clément, F., Didierlaurent, A. M., Fissette, L. A., Roman, F. P., & Boutriau, D. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00617-13 · Cited by 15

Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins

Mizuguchi, T., Ohashi, N., Nomura, W., Komoriya, M., Hashimoto, C., Yamamoto, N., Murakami, T., & Tamamura, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.020 · Cited by 12

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Boettler, T., Newsome, P. N., Mondelli, M. U., Maticic, M., Cordero, E., Cornberg, M., & Berg, T. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100113 · Cited by 477

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

Yang, N., & Shen, H.-M. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.45498 · Cited by 412

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs

Li, Z., Li, X., Huang, Y.-Y., Wu, Y., Liu, R., Zhou, L., Lin, Y., Wu, D., Zhang, L., Liu, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010470117 · Cited by 255

Malaria and COVID-19: unmasking their ties

Hussein, M. I. H., Albashir, A. A. D., Elawad, O. A. M. A., & Homeida, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03541-w · Cited by 156